We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Argent Biopharma Limited | RGT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 21.50 | 08:00:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 21.50 | 21.50 | 21.50 | 21.50 | 21.50 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 20/2/2011 15:24 by share_shark Something to bear in mind/ This article is todays date.ial report from James Faulkner of WatsHot.com Expert tipster James Faulkner provides two new tips a month and regular updates on specialist small caps site WatsHot.com. Although past performance is no guarantee of future success, and some tips have gone down in value, the average gain per tip as at 31st December 2010 across the 23 stocks tipped last year was 73.28%. To get more top tips like this, join WatsHot.com now. In this special report, James considers the recent performance of healthcare stocks and picks out those likely to perform best this year. To read more insightful analysis like this from James in his daily column and get two brand new tips each month, join WatsHot.com now. Healthcare is a sector that you can count on for solid growth for many years to come. Crucially, the growth drivers are structural. In the West we face the twin problems of an ageing population coupled with an increasing tendency towards obesity among younger people, both of which point to a steeply rising healthcare bill in the future. In the emerging economies, it is increasing affluence which is driving demand. Both arenas offer exciting growth potential for companies that are dynamic enough to take advantage of the opportunities. Investors should be aware that the sector is currently undergoing a huge transformation. The major pharmaceuticals and biotech companies are having a tough time getting over a patent cliff estimated to be worth a staggering $200 billion between 2008-12. This coincides with a period where competition from generic drug companies is increasing, whilst pricing pressure from governments and the private sector is becoming much more pronounced and will continue to do so as austerity-led reforms aim to drive down the cost of healthcare. All this has led to a dramatic decrease in the number of new patented drugs being developed as R&D budgets amongst the majors are slashed. This is throwing up some great opportunities for smaller companies which are developing their own compounds or offer R&D services which can help drive down costs through outsourcing. The other side to this is that some of the larger companies will simply have to grow by acquisition, and there are rich pickings among a small cap healthcare sector which has long been unloved by investors. What follows is my assessment of what I believe to be some of the best buying opportunities in the sector. |
Posted at 10/2/2011 21:58 by share_shark Not RGT but.............sentDid you just multiply your money nineteen-fold? By Tom Bulford Feb 10, 2011 Tom Bulford 2010 was the year of the junior miner. Every week saw some plucky explorer score unbelievable gains. But this year is likely to be different, and I've got my eye on a few other sectors that I think could see fantastic successes in 2011. Each week I send out my very best discoveries exclusively to Red Hot Penny Shares subscribers. You can find out my favourite picks for 2011 here - but more on that later... Here at Penny Sleuth, I've talked about food stocks and the remarkable recovery in UK manufacturing. But one sector that is really beginning to look exciting is biotech. Dormant for years and abandoned by investors as a non-starter, biotech looks to be on the cusp of a thrilling revival. After a string of dramatic announcements in recent months, it seems that investors have discovered a newfound enthusiasm for these stocks. Just look at what happened this week when drug researcher SAREUM HOLDINGS (LON:SAR) revealed news of another exciting breakthrough... The discovery that points to Biotech's extraordinary revival On Monday Dr Tim Mitchell, Chief Executive of the Cambridge based drug researcher, reported that its Aurora+FLT3 Kinase programme had, in a pre-clinical in-vivo study, appeared to slow the progress of cancer. Ten leukaemia patients were treated with this compound and their 'leukaemia regressed to such an extent that no detectable cancer could be found in any of the cases treated'. By contrast for those who did not receive Sareum's compound their leukaemia 'increased five to fifteen fold'. That was enough to send Sareum's share price multiplying. Having drifted along for months at a price of about 0.25p, the shares took off, hitting 1.65p the following day and 4.79p on Wednesday. It has slipped back a little today. But those lucky enough to have been holding the shares and smart enough to have got out at the top could have multiplied their money nineteen-fold in the space of just three days. |
Posted at 07/2/2011 12:10 by alby220 But i do disagree with you, in respect of genises Rob.i hope the investore here, me included ! get some sort of return But it is a outside chance now in my opinion.The Big investors here have lost a fortune based on the BoD's inept stewardship of our money. |
Posted at 31/1/2011 23:56 by stav5001 I apologise as I wanted to post sooner, but a lot was discussed and it was hard to post it all on here. It was nice to meet ASMO and his friend. Asmo has already given good general overview of events, and I do not want to bore you all by revisiting the same points. I could have asked hundreds of barbed questions at the EGM, as I know what many here have been posting, and I understand the strength of feeling, but in the end, I decided against most of them, as we were effectively presented with a "coup de etat," we had no real option but to vote YES. For me there is no point dwelling on the negative, dark side. I prefer the light as it will always pierce the darkness. David Scott's presentation was corporate, slick and well presented, I expected no less, and he did not disappoint. If I was in his shoes, I would have probably done the same, and I actually said so later, in fact I liked him. However, my real focus was really on Newco. Tim Shilton, gave a calm, concise and clear presentation, regarding Newco, it is clear from the presentation that Newcos prime objective is to concentrate its energies on generating cashflow from the existing accounts, and work with the other parties that have shown an interest in opening new accounts. All other money draining ventures will be put on hold, (which clearly makes sense). Tim also said that the last agreement with LG was like a bolt out of the blue, as it was sent out a year ago, and came back signed, a year later without a single change! Reduced Overheads, according to Percy £300,000 less p.a. Wages bill now reduced to £50K All debts settled (including filtration unit) Retention of Patents 3 year Short-term finance (£240,000) secured @ 10% per Annum. Trading losses carried forward except a small amount that was utilised for the directors exit package. Increase the revenue to Newco Regen, through use of tablet form. Tim also assured me that they will retain the same website (but modified); there will be regular trading updates; Email contact with shareholders; clarification announcement if required, 6 monthly reports , an AGM and other adhoc meetings. When I said that it was easy with today's technology, or even using youtube to buy a webcam and give an update, Tim said that he was quite interested in technology, so did not rule this out. I have said "no looking back", but I did feel compelled to ask some questions for everyone. Like why, with expected news of break even for RGT, the recent new overseas contracts, and many investors recently buying at between 3.25P to 3.75P ( including me), that a home could not have been found for 12 million shares, at a higher price, perhaps 1P-2P at least. I also asked WHO.... bought the shares at that price. David Scot simply replied that the recent placing reflected the major placing at 0.5P. Percy Lomax implied that they had exhausted all sources of potential investors, and that the 12M RGT shares were placed with "an investor" who has supported RGT to the tune of £700,000 in total (that equates to a lot of shares at last years prices)? He also said that he wished, I had picked up the telephone and called earlier as he would have been more than happy to sell them to me, or any other RGT investors. I also made it clear that I found it very strange that I (a small PI and newcomer), owned almost as many shares as all RGT the directors combined, and indeed would have held more, if the news had not broken when it did. It was then that Percy said that his losses totalled £750,000. The Directors are not getting, or claiming back-pay for the years on half-salary, Percy said. The cash and share-options etc. are for contract termination. Clearly, if the company had ceased they would have received £0. The 5 year warrants at 0.01p are being issued as a tax mechanism, and are tied to the amount that they (the Directors) are owed. To put it simply they are owed £378,562.50 in total, less £80,000 which is being paid in cash following the demerger. So they will still be owed £298,562.50. Now if you divide this by the placing price of 0.5P, you get 597,125,000 shares. My understanding is that this is how many share options they will have, but they were issued at a nominal 0.01P to save tax instead. I tackled, them on this point, David Scott said he was very happy that I had raised this point, but it took a while for the NOMAD to put the meat on the bones. I brought the whole 0.01 options issue up, when I questioned just how fast the new ADS company could grow, when it would have to constantly overcome, this overhang / dilution which would be added to the existing 300,000,000 new ReGen ordinary shares, whenever the price looked like rising. David Scott assured me that" Everyone understood the position " and that there would be no wholesale selling, thus destablising their efforts. I also added that their holding of 29.9% of the new ADS Company, meant that they only needed an additional 0.1% to launch a takeover, if the new company was doing well. All in all, this all bodes well for ADS, these guys have played a blinder and pretty much covered all their bases, and I said so. I told David Scott that if I was negotiating for us, I would have at least held out for the £240,000 as a payment to Newco, not a loan. I also questioned the 10% pa, interest payments, not generous, in fact similar to what prospecting mining companies on AIM have to pay. Let's face reality, at the end of the day RGT was in a position of weakness, and everyone wanted their share. We now have two bites of the cherry. The New investment company clearly has some very intelligent professional backers, who do not want to see it fail, they have achieved their first goal, but most importantly for most of us here, is that Tim Shilton, seems quietly confident, and is still very positive about our new delisted companies future, with it's new low cost, efficient format, and global aspirations, HE (who knows most) believes we can fly, so why should I allow negative thoughts to stop the flight of a PHOENIX! We do not have a great deal to lose from where we are right now, but we do have everything to gain. Let's think positively, thank those that can assist the new company (like GENISES), and wait for a new, and brighter dawn! I wish Tim well, may he infect new and existing clients, with a reborn enthusiasm! Fortuna audax iuvat, (Fortune favours the Brave). Onwards and upwards! |
Posted at 17/1/2011 21:44 by haywards26 They do all say every dog has it's day. Buying such companies only adds to the chances of success going against the ordinary investor and reducing. As surely share prices in a normal world are driven by companies values, which in turn are driven by profits/asset values.Many companies are driven by blue sky valuations, but eventually the majority come crashing back down to earth with a bang leaving investors with empty pockets. Trying to time and second guess the markets is IMO a mugs game. The most successful investors throughout history would also say the same. Some people win it big with the lottery and in casino's but the majority end up with less money in their wallet than before the event. AIMHO |
Posted at 17/1/2011 21:19 by haywards26 Sadly many investors here got caught up thinking RGT would bring them untold riches. When in reality there were no assets, no profits and no chance of such occurances. The AIM market in general is somewhat like a casino, yet alone companies floated within AIM that are loss making, hold no meaningful assets and constantly dilute their faithful investors. I could not believe the posters on here time and time again being spun dreams and lapping it up year after year even despite the accounts and share price performance being continually dire. Lessons need to be learnt by many, and sadly their bank balances shall be significantly lighter with this. Lessons to learn - avoid loss making companies, avoid companies with large debts, avoid companies with no assets, avoid companies that constantly issue shares, and finally buy the management. Sadly RGT were a big no no on nearly every single factor. |
Posted at 13/1/2011 21:25 by the_doctor2 'If you imagine that JP Jenkins is some buzzy City firm with screens ablaze and trades going all the time I'm afraid you are mistakes'nobody thought that - clearly old Colin perhaps did given he bothered to look I see no great problem with a matched system, however quiet, since IF you want to sell and someone wants to buy, you can still arrive at a price acceptable to both It means you cant bail out in a hurry, but if there are willing buyers - and there may be - you can still get a fair price. It's a spread that messes things up, not liquidity per se 'and if you are with an online broker you are stuffed because they wont be able to deal with them' yeah, well done colin - it's going private! Right, my personal (no advice intended) view of the situation: 1. We now know that while the Q4 2010 profitability target hasnt been reached, the company has a loan facility, that is expected to be sufficient for getting there. Bearing in mind the payments out required, such as the remainder of the filtration unit, that gives some indication as to how close they think they'll be - CLOSE! 2. All the talk of PL screwing people over etc. is NONSENSE Shareholders lose virtually nothing with this arrangement. It is little different from the previous situation apart from the fact that shares will no longer be tradeable. In fairness, why should they hinder the chances of getting to breakeven just for the 3. It was clear from the placings at lower and lower levels that something drastic would have to be done if they couldnt issue a bit more at those prices. As I pointed out, this resulted in a death spiral. The co. had two main problems - the dilution from placings and the cash burn. They'd done all they could to reduce cash burn as a listed company. So, the plan was to delist. Makes a lot of sense, despite the grumbles of a few traders 4. The company still needed to get its finances sorted out a bit more - especially if it was to lay off staff. The advisor suggested a plan in which oil investors could get a listed vehicle, paying RGT for the privilege through minority shares in that, warrants and a loan. Actually, I dont really see why they had to give RGT anything - are there not various other bust companies that could be used??? (thoughts?) 5. You get shares and warrants in what essentially becomes a random oil investment company (I'm not exactly sure what its investment strategy is and as far as I can see, by giving away a share to RGT holders, it's already sharply down on its investment!) The aim may be for the investment company to later bulk up by more funds, thereby diluting out the negative aspects - ie. the why bother the value of RGT shares would still stay the same dependent upon performance 6. The get out for investors is not really the private trading facility, but a later relisting on PLUS, or a buyout. I can tell you now that IF they become sustainable, with just one product, a neat business and limited creditors, this will be easy to sell Sorry to go on - my aim here has honestly been to try and help folk amidst the misinformation and panic Initially I did think shareholders had been totally screwed,. but reading further, I no longer think that and if sustainability really is just in H1 2011, the company may do just fine |
Posted at 13/1/2011 09:22 by bongo bwana I don't know what anyone can do at this stage shareholders have been ambushed and massacred, mercilessly by PL's strategy for the company.He is a complete and utter failure as a CEO of a Plc. Various shareholders here were absolutely certain that a number of Colostrinin commercialisation deals were advancing down the pipeline for conclusion. Some were relatively imminent, so why this (in chess terms) castling manouvre???? What sparked the very recent spike in demand for RGT shares? It now seems that word had been given to a select band of investors (there is always a select band of investors and PI will rarely be amongst them) of an imminent deal and that ordinary shares would be available at .5p Ive lost count of the number of times I actually considered selling my holding here this past week (I would have made a small but respectable profit) but was convinced that something material to RGT's future was afoot, and decided to hold on - I even added another 100,000 after 2pm yesterday. When I got them for almost a half penny less than I expected i knew something was wrong and then another deal went through at a further reduction before the RNS. Im as mad as hell. Im sickened that I didnt follow my gut instinct, which I usually trust. Im down £8,000 and thats somewhat less than a lot of others here. No time for further regrets but I do wish Gant had advised of his recent offloading actions. Well done to him I say with sincerity. I hope 'Maysun' starts putting the "LOL" back into his contributions here. We all need it and from the looks of glass half empty things RIGHT NOW it seems we are locked into this nightmare for a number of years to come without much hope of break even for quiet a while yet. I suspect the opportunity cost of this event is going to be massively expensive to most investors. |
Posted at 12/1/2011 19:36 by maysun Intersting situation.Must admit this is first time I come across something like this.Spoken to my frind and Stav500. We agree its best to let the dust settle and see what comes our way. Our interpretation of what happen here is: The new investors are looking for a listed vechicle to reverse a mining business into a shell company. They came across RGT,after dual dilligent,see vlaues in the RGT (CLN in particular),so they tries to kill two birds with one stone. In order to offer something to existing RGT investors, they propose to offer them new shares in the new RGT company. After spoken to my friend and Stav500,we decided to hold onto our shares. I am a born optimist,I do see positves in the new arrangemnt,specially if indeed the new investors have a ming business identified and ready for a reverse take over. IMHO,the company never had any difficulty in raising fund even when the business was in a worse situation. Have the BOD see some short term upside potential with the new arrangement? We all have to wait and see. All is not lost, we will find out soon enough.........good luck all!!!! |
Posted at 12/1/2011 17:55 by acta_topup Like all holders here, I am absolutely shocked & dismayed. On the face of it this appears to be one hell of a slap in the face for all private investors here, many of whom have supported the company through far worse times over the last 10 years. I quote the most recent interim report from 23rd September 2010:"These are the best figures in terms of sales and Company performance that ReGen has ever presented...This half year sales figure is greater than any full-year figure previously achieved." And further on: "The Directors would comment that, even with the tighter funding environment that has come since the credit crunch, the Company has managed to fund the level of deficit as is indicated by our ability to raise £601,000 from 1 January 2010 to 16 July 2010. This has enabled us to pay down debt acquired during the more stringent environment of 2009 as well as providing working capital. The latest figures show that ReGen is getting nearer to profitability. We have stated that we believe ReGen will obtain sustainable profitability in the 4th Quarter of 2010. The Company has a number of initiatives in place, described in this statement, to bring about this situation." There is nothing to suggest a material change that could have transpired between September and January. If anything, with further interest in the company's porduct, especially from LG, we could have expected an even better financial position in early 2011. No, there appear to be other malign forces at work here. With the resurgent interest in the company, both from long standing and new investors, there is absolutely no question that they could not have obtained further cash from smaller placings at a 10-15% discount to the shareprice. The shareprice peaked at 3.88p last week. Notwitstanding the time taken to arrange a placing, they could certainly have gained access to necessary funds after the South Korea deal with an accompanying trading statement to show where the money was going and at what point the company was at on its road to recovery. This could certainly have been achieved at greater than 3p. Instead, the company ReGen Therapeutics (the maker of CLN) will no longer exist with regard to normal shareholders as a going concern. Who is going to trade his shares on the JP Jenkins system which is a false market? I will have to read and digest the RNS in more detail, but my gut instinct tells me that much has been held from us over the last few months and that this must be accountable to the BofD and to Percy Lomax in particular. My feeling is that it may be time to research ways in which this deal might be blocked and the BofD removed. We all understand the potential of the product, but it is the way that the company has been managed and in particular the contempt with which it has treated its private investors that has been the huge problem here. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
